Science & Product
Unlocking the untapped potential of fexofenadine for patients worldwide.
The Untapped Potential of Fexofenadine
Fexofenadine is a well-known second-generation antihistamine with an established safety profile. While widely used for allergies, its potential in dermatology and inflammatory conditions remains largely unexplored.
OrchestratePharma is pioneering the development of novel topical and systemic formulations of fexofenadine to address conditions where current treatments fall short — including atopic dermatitis (eczema), chronic spontaneous urticaria, and other inflammatory skin diseases.
FexoTopic
Eczema Ease & Prevent
FexoTopic is our lead product candidate — a novel topical formulation of fexofenadine designed to provide multi-modal relief for eczema patients through a unique combination of mechanisms.
Six Key Mechanisms
H1R Blocking
Potent H1 receptor antagonism reduces histamine-mediated itch and inflammation.
Anti-inflammatory
Demonstrated anti-inflammatory properties beyond antihistamine effects, reducing cytokine production.
Dysbiosis Correction
Potential to restore healthy skin microbiome balance disrupted in eczema and other skin conditions.
Moisture Retention
Supports skin barrier function and helps maintain proper hydration levels.
Barrier Repair
Promotes restoration of the skin's natural protective barrier compromised in dermatological conditions.
Antimicrobial
Exhibits antimicrobial properties that may help prevent secondary infections in damaged skin.
Learn More About Our Pipeline
Explore our full product portfolio and see how we are advancing fexofenadine-based therapeutics.
View FexoTopic